MeiraGTx Holdings (MGTX) Common Equity (2017 - 2025)
MeiraGTx Holdings posted quarterly Common Equity of -$5.8 million for Q4 2025, down 108.54% year-on-year from $67.8 million in Q4 2024, and up 85.72% on a QoQ basis from -$40.6 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 9 years of Common Equity data on file, last reported at -$5.8 million in Q4 2025.
- For the quarter ending Q4 2025, Common Equity fell 108.54% year-over-year to -$5.8 million; the trailing twelve-month figure through Dec 2025 stood at -$5.8 million (down 108.54% YoY), and the FY2025 full-year result was -$5.8 million, down 108.54% from the prior year.
- Common Equity for Q4 2025 stood at -$5.8 million, up from -$40.6 million in the prior quarter.
- Across five years, Common Equity topped out at $220.8 million in Q1 2021 and bottomed at -$40.6 million in Q3 2025.
- The 5-year median for Common Equity is $119.7 million (2022), against an average of $107.1 million.
- The widest annual swing landed in 2024, when Common Equity surged 34.93%; it then plunged 142.36% in 2025.
- A 5-year view of Common Equity shows it stood at $185.4 million in 2021, then plunged by 36.5% to $117.7 million in 2022, then gained by 17.36% to $138.2 million in 2023, then slumped by 50.91% to $67.8 million in 2024, then plunged by 108.54% to -$5.8 million in 2025.
- The last three Common Equity figures came in at -$5.8 million (Q4 2025), -$40.6 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.42 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 35.63 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 13.21 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.08 Bn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | -5.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.79 Mn |
| Sep 30, 2025 | -40.56 Mn |
| Jun 30, 2025 | 2.96 Mn |
| Mar 31, 2025 | 33.10 Mn |
| Dec 31, 2024 | 67.83 Mn |
| Sep 30, 2024 | 95.74 Mn |
| Jun 30, 2024 | 80.04 Mn |
| Mar 31, 2024 | 121.73 Mn |
| Dec 31, 2023 | 138.18 Mn |
| Sep 30, 2023 | 91.89 Mn |
| Jun 30, 2023 | 123.53 Mn |
| Mar 31, 2023 | 90.22 Mn |
| Dec 31, 2022 | 117.74 Mn |
| Sep 30, 2022 | 122.67 Mn |
| Jun 30, 2022 | 141.97 Mn |
| Mar 31, 2022 | 161.29 Mn |
| Dec 31, 2021 | 185.40 Mn |
| Sep 30, 2021 | 187.84 Mn |
| Jun 30, 2021 | 205.72 Mn |
| Mar 31, 2021 | 220.79 Mn |
| Dec 31, 2020 | 238.56 Mn |
| Sep 30, 2020 | 179.09 Mn |
| Jun 30, 2020 | 172.77 Mn |
| Mar 31, 2020 | 184.93 Mn |
| Dec 31, 2019 | 190.80 Mn |
| Sep 30, 2019 | 194.89 Mn |
| Jun 30, 2019 | 129.56 Mn |
| Mar 31, 2019 | 144.42 Mn |
| Dec 31, 2018 | 81.06 Mn |
| Sep 30, 2018 | 96.34 Mn |
| Jun 30, 2018 | 108.47 Mn |
| Mar 31, 2018 | -60.92 Mn |
| Dec 31, 2017 | -47.37 Mn |